Cbay stock forecast.
According to analyst projections, CBAY’s forecast low is $20.00 with $34.00 as the target high. To hit the forecast high, the stock’s price needs a -82.21% plunge from its current level, while the stock would need to soar -7.18% for it to hit the projected low. Cymabay Therapeutics Inc (CBAY) estimates and forecasts
Cymabay Therapeutics 's revenue in 2023 is $31,016,000. On average, 7 Wall Street analysts forecast CBAY's revenue for 2023 to be $3,523,442,178, with the lowest CBAY …Stock Price Forecast. The 14 analysts offering 12-month price forecasts for International Business Machines Corp have a median target of 145.00, with a high estimate of 179.00 and a low estimate ...EXEL Stock 12 Months Forecast. Based on 13 Wall Street analysts offering 12 month price targets for Exelixis in the last 3 months. The average price target is $25.75 with a high forecast of $32.00 and a low forecast of $18.00. The average price target represents a 25.06% change from the last price of $20.59.Great weather can motivate you to get out of the house, while inclement weather can make you feel lethargic. When the weather’s great we want to be outside enjoying it. For the best regional weather forecasts check out AccuWeather.
CBAY one year fore… Wednesday, November 23, 2022 Edit. emporia hotels in marriott. marriott hotels in emporia va. Quality Inn Emporia November 23, 2022 Edit. Jill Scott wallpaper. ... cbay stock forecast cnn. Based on 5 Wall Street analysts offering 12 month price targets for CymaBay Therapeutics in the last 3 months. CBAY one year …CBM Bancorp, Inc. (CBMB) share price prediction for 2023, 2024, 2025, 2026 and 2027. CBMB one year forecast. CBM Bancorp stock monthly and weekly forecasts.há 4 dias ... For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, ...
Find the latest CymaBay Therapeutics, Inc. (CBAY) stock quote, history, news and other vital information to help you with your stock trading and investing.What happened. Shares of CymaBay Therapeutics ( CBAY -1.16%) were up more than 37% as of 11:15 a.m. ET on Friday. The clinical-stage biotech saw its shares rise after Ipsen and Genfit announced ...
Xenon Pharmaceuticals Inc. 28.97. +0.24. +0.84%. Get CymaBay Therapeutics Inc (CBAY:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. CymaBay Therapeutics Inc. is a biopharmaceutical company. It is focused on the development and commercialization of proprietary new medicines for important human diseases. The Company's lead ...7 brokers have issued 12-month price targets for Verastem's stock. Their VSTM share price targets range from $21.00 to $36.00. On average, they anticipate the company's share price to reach $29.71 in the next year. This suggests a possible upside of 362.1% from the stock's current price. View analysts price targets for VSTM or view top-rated ...Stock Price Forecast The 6 analysts offering 12-month price forecasts for Aldeyra Therapeutics Inc have a median target of 9.00, with a high estimate of 11.00 and a low estimate of 7.00.What happened. A significant miss on quarterly earnings combined with a big change in its C-suite put a damper on CymaBay Therapeutics (CBAY 3.03%) stock this week. According to data compiled by S ...
TipRanks | Stock Market Research, News and Analyst Forecasts - TipRanks.com
Cymabay Therapeutics (CBAY) Company Description. CymaBay Therapeutics Inc is a clinical-stage biopharmaceutical company. Its main business involves the development of therapeutics such as Arhalofenate, MBX-8025, and MBX-2982. These drugs are intended to treat serious metabolic disorders. Arhalofenate is used to treat gout, MBX-2982 is an oral ...
Sep 8, 2023 · He kept his outperform rating on CBAY stock and raised his price target to 20 from 18. Notably, CymaBay stock has a best-possible Relative Strength Rating of 99, according to IBD Digital. This ... Find the latest CymaBay Therapeutics, Inc. (CBAY) stock quote, history, news and other vital information to help you with your stock trading and investing. Stock Price Forecast. The 22 analysts offering 12-month price forecasts for Thermo Fisher Scientific Inc have a median target of 519.50, with a high estimate of 600.00 and a low estimate of 435.00 ...Stock Price Forecast. The 1 analysts offering 12-month price forecasts for Swvl Holdings Corp have a median target of 37.50, with a high estimate of 37.50 and a low estimate of 37.50. The median ...Nov 29, 2023 · Future criteria checks 2/6. CymaBay Therapeutics is forecast to grow earnings and revenue by 47.6% and 61.6% per annum respectively. EPS is expected to grow by 45.7% per annum. Return on equity is forecast to be -57.1% in 3 years.
CBAY is pre-revenue, given its pre-clinical status. It recorded $30mm in cash on the balance sheet last report , with an additional $122mm in marketable securities. Subsequently, it had $150mm in ...Latest CBAY News | Press Releases See All CBAY News Today’s Trading Data as of 3:59pm ET, 11/20/2023 Growth & Valuation Competitors Data as of 4:00pm ET, 11/20/2023 Financials Profile... ACIU Stock 12 Months Forecast. Based on 2 Wall Street analysts offering 12 month price targets for AC Immune SA in the last 3 months. The average price target is $16.00 with a high forecast of $16.00 and a low forecast of $16.00. The average price target represents a 417.80% change from the last price of $3.09.Weather forecasts are essential tools for planning our daily activities, especially when it comes to the next 10 days. Understanding a weather 10 day forecast can help us make informed decisions about outdoor events, travel plans, or even w...September 8, 2023 at 1:12 PM · 3 min read. Shares of clinical-stage biopharmaceutical company CymaBay Therapeutics, Inc. CBAY gained after it announced positive top-line results from its late ...A price increase of 41.9% over the past four weeks ensures that the trend is still in place for the stock of this company. Moreover, CBAY is currently trading at 92.9% of its 52-week High-Low ...
What are analysts’ forecasts for CBAY stock? Forecst.com predicts future values using technical analysis of a large number of analytical parameters. CBAY stock returns are also predicted based on historical data. According to our research, CBAY stock is a bad long-term investment.
He kept his outperform rating on CBAY stock and raised his price target to 20 from 18. Notably, CymaBay stock has a best-possible Relative Strength Rating of 99, according to IBD Digital. This ...Discover historical prices for CBAY stock on Yahoo Finance. View daily, weekly or monthly format back to when CymaBay Therapeutics, Inc. stock was issued.CymaBay Therapeutics, Inc. (NASDAQ:CBAY) Q3 2023 Earnings Call Transcript November 7, 2023 CymaBay Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.32 EPS, expectations were $-0.3. Operator: Good day, ladies and gentlemen, and welcome to CymaBay’s Third Quarter 2023 ...The consensus price target of analysts on Wall Street is $24.42, which implies an increase of 21.66% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $20.00 and $34.00 respectively. As a result, CBAY is trading at a discount of -77.73% off the target high and -4.55% off the low.The CymaBay Therapeutics stock forecast for tomorrow is $ 19.01, which would represent a -0.48% loss compared to the current price. In the next week, the price of CBAY is expected to decrease by -5.95% and hit $ 17.96. As far as the long-term CymaBay Therapeutics stock forecast is concerned ...CymaBay Therapeutics Inc (CBAY) stock is trading at $11.76 as of 11:26 AM on Monday, Jul 3, a rise of $0.81, or 7.39% from the previous closing price of $10.95. The stock has traded between $10.95 and $11.77 so far today. Volume today is low. So far 1,522,720 shares have traded compared to average volume of 2,310,531 shares.According to . 9 Wall Street analysts that have issued a 1 year CBAY price target, the average CBAY price target is $24.56, with the highest CBAY stock price forecast at $34.00 and the lowest CBAY stock price forecast at $15.00.16 Wall Street analysts have issued 12 month price targets for Exelixis' stock. Their EXEL share price targets range from $18.00 to $32.00. On average, they anticipate the company's stock price to reach $25.44 in the next twelve months. This suggests a possible upside of 18.3% from the stock's current price. View analysts price …Over the past 3 months, 14 analysts have published their opinion on CymaBay Therapeutics (NASDAQ:CBAY) stock. These analysts are typically employed by large Wall Street banks and tasked with ...
Find the latest CymaBay Therapeutics, Inc. (CBAY) stock quote, history, news and other vital information to help you with your stock trading and investing.
16 brokerages have issued 1-year price targets for Exelixis' stock. Their EXEL share price targets range from $18.00 to $32.00. On average, they expect the company's stock price to reach $25.44 in the next twelve months. This suggests a possible upside of 19.6% from the stock's current price. View analysts price targets for EXEL or view top ...
Stock Price Forecast. The 10 analysts offering 12-month price forecasts for Viking Therapeutics Inc have a median target of 34.00, with a high estimate of 40.00 and a low estimate of 28.00. The ...Dec 1, 2023 · The consensus price target of analysts on Wall Street is $24.42, which implies an increase of 21.66% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $20.00 and $34.00 respectively. As a result, CBAY is trading at a discount of -77.73% off the target high and -4.55% off the low. Nov 24, 2023 · Stock analysis for Cymabay Therapeutics Inc (CBAY:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Stock Price Forecast. The 23 analysts offering 12-month price forecasts for Nokia Oyj have a median target of 4.39, with a high estimate of 7.60 and a low estimate of 3.49. The median estimate ...Find the latest Cidara Therapeutics, Inc. (CDTX) stock quote, history, news and other vital information to help you with your stock trading and investing.41 Wall Street research analysts have issued 12-month target prices for Shopify's shares. Their SHOP share price targets range from $41.00 to $82.00. On average, they predict the company's share price to reach $65.09 in the next twelve months. This suggests that the stock has a possible downside of 8.3%.Sep 8, 2023 · He kept his outperform rating on CBAY stock and raised his price target to 20 from 18. Notably, CymaBay stock has a best-possible Relative Strength Rating of 99, according to IBD Digital. This ... As the old saying goes, “Forewarned is forearmed.” This sentiment holds true when it comes to weather forecasting as well. One of the primary advantages of a 30-day extended weather forecast is the ability to plan ahead with confidence.At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.
Stocks trading online may seem like a great way to make money, but if you want to walk away with a profit rather than a big loss, you’ll want to take your time and learn the ins and outs of online investing first. This guide should help get...People use statistics daily for weather forecasts, predicting disease, preparing for emergencies, medical research, political campaigns, tracking sales, genetics, insurance, the stock market and quality testing.What are analysts’ forecasts for CBAY stock? Forecst.com predicts future values using technical analysis of a large number of analytical parameters. CBAY stock returns are also predicted based on historical data. According to our research, CBAY stock is a bad long-term investment.The average Guardforce Ai Co stock price prediction forecasts a potential upside of 260.82% from the current GFAI share price of $3.88. What is GFAI's forecast return on assets (ROA) for 2023-2026? (NASDAQ: GFAI) forecast ROA is N/A, which is lower than the forecast US Security & Protection Services industry average of N/A.Instagram:https://instagram. american express stocksbest real estate investment appstop stock screenersjepi roth ira If you want to keep up to date on the stock market you have a device in your pocket that makes that possible. Your phone can track everything finance-related and help keep you up to date on the world markets.View the latest CymaBay Therapeutics Inc. (CBAY) stock price, news, historical charts, analyst ratings and financial information from WSJ. gld returnshealth insurance carriers in maryland See the latest CymaBay Therapeutics Inc stock price (CBAY:XNAS), related news, valuation, dividends and more to help you make your investing decisions. aa stok When planning outdoor activities or making travel arrangements, having access to accurate weather forecasts is crucial. One commonly used tool is the 7 day weather forecast, which provides an outlook for the upcoming week.A price increase of 41.9% over the past four weeks ensures that the trend is still in place for the stock of this company. Moreover, CBAY is currently trading at 92.9% of its 52-week High-Low ...Find the latest AFC Gamma, Inc. (AFCG) stock quote, history, news and other vital information to help you with your stock trading and investing.